ESR1 and acute myeloid leukemia: The algorithm proposed successfully classified: (1) the AML subtypes in accord with the FAB classification schema (e.g. M0 subtype was arrayed closest to stem cells); (2) breast carcinoma based on estrogen receptor (ER) status; and (3) confirmed our initial findings in liposarcomas as described above.